Cardiovascular diseases (CVD) continue to be the top global killer, responsible for one in every three deaths in 2023, according to a new study published in the Journal of the American College of Cardiology (JACC). The number of deaths due to CVD skyrocketed to 19.2 million in 2023, up from 13.1 million in 1990, driven by population growth, ageing, and rising rates ofobesityand diabetes. Ischemicheart diseaseand stroke affect millions worldwide, with men facing higher risks than women, especially after age 50. High body mass index and elevated blood sugar emerged as the fastest-growing metabolic risk factors. The study, based on the Global Burden of Disease data from 204 countries, emphasizes significant geographic disparities in CVD impact that go beyond income differences. Nearly 80% of these health burdens stem from modifiable risks like obesity, poor diet, and pollution, emphasizing the critical need for targeted prevention and health policies tailored to regional needs. REFERENCE:Global, Regional, and National Burden of Cardiovascular Diseases and Risk Factors in 204 Countries and Territories, 1990-2023. JACC. null2025, 0 (0) .https://doi.org/10.1016/j.jacc.2025.08.015
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
0 Comments
Post a comment
No comments yet. Be the first to comment!